These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25066617)

  • 1. Evaluating subjective domains of antipsychotic-induced adverse effects using heart rate variability.
    Chang JS; Hwang SS; Yi SH; Kim Y; Lee YS; Kim YS; Jung HY
    Psychiatry Clin Neurosci; 2015 May; 69(5):283-91. PubMed ID: 25066617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine on heart rate dynamics and their relationship with therapeutic response in treatment-resistant schizophrenia.
    Kim JH; Yi SH; Lee J; Kim YS
    J Clin Psychopharmacol; 2013 Feb; 33(1):69-73. PubMed ID: 23277266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia.
    Bär KJ; Koschke M; Berger S; Schulz S; Tancer M; Voss A; Yeragani VK
    J Clin Psychopharmacol; 2008 Dec; 28(6):694-8. PubMed ID: 19011440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects.
    Kim JH; Yi SH; Yoo CS; Yang SA; Yoon SC; Lee KY; Ahn YM; Kang UG; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):371-8. PubMed ID: 14751435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone.
    Chang JS; Yoo CS; Yi SH; Hong KH; Lee YS; Oh HS; Jung DC; Kim YS; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):924-9. PubMed ID: 20423720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between akathisia and subjective tolerability in patients with schizophrenia.
    Kim JH; Byun HJ
    Int J Neurosci; 2010 Jul; 120(7):507-11. PubMed ID: 20583904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia.
    Iwamoto Y; Kawanishi C; Kishida I; Furuno T; Fujibayashi M; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
    BMC Psychiatry; 2012 Nov; 12():199. PubMed ID: 23151241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics.
    Kim JH; Ann JH; Kim MJ
    J Clin Pharm Ther; 2011 Apr; 36(2):172-8. PubMed ID: 21366646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
    Hwang SS; Jung DC; Ahn YM; Kim SH; Kim YS
    Int Clin Psychopharmacol; 2010 Mar; 25(2):83-90. PubMed ID: 20065855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the associations between neurocognitive function and neuroleptics side effects.
    Hwang SS; Kim Y; Yun DY; Kim YS; Jung HY
    J Psychiatr Res; 2012 Jul; 46(7):913-9. PubMed ID: 22551660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.
    Lambert TJ; Cock N; Alcock SJ; Kelly DL; Conley RR
    Hum Psychopharmacol; 2003 Jul; 18(5):405-11. PubMed ID: 12858330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart rate variability in schizophrenic patients treated with antipsychotic agents].
    Cohen H; Loewenthal U; Matar M; Kotler M
    Harefuah; 2001 Dec; 140(12):1142-7, 1231. PubMed ID: 11789296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished neurocardiac dynamics associated with antipsychotic-induced extrapyramidal syndrome.
    Kim JH; Yi SH; Park KT; Ahn YM; Lee KY; Yang SA; Kim YS
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):459-63. PubMed ID: 16343860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.